Novo Nordisk's weight loss drug Wegovy to run short amid contract manufacturer hiccup

Demand for Novo Nordisk’s obesity medicine Wegovy is high, but a manufacturing hitch with one of the Danish company’s partners has put near-term supply in jeopardy.